{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:12:31Z","timestamp":1793059951180,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010438","name":"Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.cgh.2024.09.038","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T11:58:50Z","timestamp":1733918330000},"page":"1308-1319.e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Global Epidemiology and Characteristics of Metabolic Dysfunction-associated Steatotic Liver Disease in Type 1 Diabetes Mellitus: An Updated Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3695-9701","authenticated-orcid":false,"given":"Matheus","family":"Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Al-Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira Mohamad","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane Alves","family":"Villela-Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2024.09.038_bib1","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2024.09.038_bib2","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"NAFLD Nomenclature consensus group. A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2024.09.038_bib3","first-page":"691","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.09.038_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156014","article-title":"Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers","volume":"160","author":"Mantovani","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.cgh.2024.09.038_bib5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.09.038_bib6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2468-1253(23)00157-7","article-title":"Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis","volume":"8","author":"Huang","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.09.038_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrendo.2017.173","article-title":"Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus","volume":"14","author":"Targher","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.cgh.2024.09.038_bib8","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(21)00246-1","article-title":"Obesity in people living with type 1 diabetes","volume":"9","author":"Van der Schueren","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.cgh.2024.09.038_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/20420188211055557","article-title":"NAFLD in type 1 diabetes: overrated or underappreciated?","volume":"12","author":"Mertens","year":"2021","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.cgh.2024.09.038_bib10","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1210\/clinem\/dgaa575","article-title":"Prevalence of nonalcoholic fatty liver disease (NAFLD) in patients with type 1 diabetes mellitus: a systematic review and meta-analysis","volume":"105","author":"De Vries","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cgh.2024.09.038_bib11","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2337\/dc20-3175","article-title":"The relationship between body fat distribution and nonalcoholic fatty liver in adults with type 1 diabetes","volume":"44","author":"Parente","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cgh.2024.09.038_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13098-021-00649-0","article-title":"Prevalence of non-alcoholic fatty liver disease and its associated factors in individuals with type 1 diabetes: a cross-sectional study in a tertiary care center in Brazil","volume":"13","author":"Barros","year":"2021","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.cgh.2024.09.038_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109819","article-title":"Metabolic determinants of NAFLD in adults with type 1 diabetes","volume":"186","author":"Serdarova","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.cgh.2024.09.038_bib14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1055\/a-1666-0431","article-title":"Shear wave elastography reveals a high prevalence of NAFLD-related fibrosis even in type 1 diabetes","volume":"130","author":"Meyer","year":"2022","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.cgh.2024.09.038_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109827","article-title":"Prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with surrogate markers of insulin resistance in patients with type 1 diabetes","volume":"186","author":"de Vries","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.cgh.2024.09.038_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2023.101477","article-title":"Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus","volume":"49","author":"Csermely","year":"2023","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.cgh.2024.09.038_bib17","article-title":"Prevalence, risk factors and diagnostic accuracy of non-invasive tests for NAFLD in people with type 1 diabetes","volume":"5","author":"Mertens","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.cgh.2024.09.038_bib18","doi-asserted-by":"crossref","DOI":"10.20452\/pamw.16553","article-title":"Indirect insulin resistance markers are associated with nonalcoholic fatty liver disease in type 1 diabetes","volume":"133","author":"Grzelka-Wo\u017aniak","year":"2023","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.cgh.2024.09.038_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2023.108405","article-title":"Prevalence and clinical determinants of non-alcoholic fatty liver disease by liver scores in adults with type 1 diabetes","volume":"37","author":"Lundholm","year":"2023","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.cgh.2024.09.038_bib20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/ejendo\/lvae043","article-title":"Prevalence and predictive features of metabolic dysfunction-associated steatotic liver disease in type 1 diabetes","volume":"190","author":"Fuhri Snethlage","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cgh.2024.09.038_bib21","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1007\/s40618-024-02333-2","article-title":"Blood glucose control and metabolic dysfunction-associated steatotic liver disease in people with type 1 diabetes","volume":"47","author":"Della Pepa","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.cgh.2024.09.038_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12933-024-02171-9","article-title":"Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabetes: an 11-year observational study","volume":"23","author":"Garofolo","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cgh.2024.09.038_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2023.101497","article-title":"MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus","volume":"50","author":"Mantovani","year":"2024","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.cgh.2024.09.038_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.cgh.2024.09.038_bib25","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamasurg.2021.0522","article-title":"MOOSE reporting guidelines for meta-analyses of observational studies","volume":"156","author":"Brooke","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.cgh.2024.09.038_bib26","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1177\/0962280219889080","article-title":"DEPRESsion Screening Data (DEPRESSD) Collaboration. Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis","volume":"29","author":"McGrath","year":"2020","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.cgh.2024.09.038_bib27","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","article-title":"Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement","volume":"65","author":"Hoy","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cgh.2024.09.038_bib28","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.cgh.2024.09.038_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.cgh.2024.09.038_bib30","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1136\/bmj.315.7121.1533","article-title":"Meta-analysis: principles and procedures","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2024.09.038_bib31","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s40618-019-01031-8","article-title":"Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes","volume":"42","author":"Cipponeri","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.cgh.2024.09.038_bib32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12072-017-9840-z","article-title":"The utility of noninvasive scores in assessing the prevalence of nonalcoholic fatty liver disease and advanced fibrosis in type 1 diabetic patients","volume":"12","author":"Singh","year":"2018","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2024.09.038_bib33","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/dom.12973","article-title":"Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes","volume":"19","author":"Cusi","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.cgh.2024.09.038_bib34","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/1753-0407.12539","article-title":"Low prevalence of non-alcoholic fatty liver disease in patients with type 1 diabetes is associated with decreased subclinical cardiovascular disease","volume":"9","author":"Serra-Planas","year":"2017","journal-title":"J Diabetes"},{"key":"10.1016\/j.cgh.2024.09.038_bib35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ijcard.2016.10.040","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes","volume":"225","author":"Mantovani","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cgh.2024.09.038_bib36","article-title":"Nonalcoholic fatty liver disease is associated with increased carotid intima-media thickness in type 1 diabetic patients","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.cgh.2024.09.038_bib37","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/dme.12805","article-title":"Type 1 diabetes is not associated with an increased prevalence of hepatic steatosis","volume":"32","author":"Petit","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/j.cgh.2024.09.038_bib38","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/hep.27098","article-title":"Prevalence and natural history of histologically proven chronic liver disease in a longitudinal cohort of patients with type 1 diabetes","volume":"60","author":"Harman","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2024.09.038_bib39","first-page":"535","article-title":"Increased prevalence of cardiovascular disease in type 1 diabetic patients with non-alcoholic fatty liver disease","volume":"35","author":"Targher","year":"2012","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.cgh.2024.09.038_bib40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s13340-011-0061-8","article-title":"Increased prevalence of diabetic complications in Japanese patients with type 1 diabetes and nonalcoholic fatty liver disease","volume":"3","author":"Yoneda","year":"2012","journal-title":"Diabetol Int"},{"key":"10.1016\/j.cgh.2024.09.038_bib41","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.4158\/EP14044.OR","article-title":"Clinical profile of nonalcoholic fatty liver disease among young patients with type 1 diabetes mellitus seen at a diabetes speciality center in India","volume":"20","author":"Vendhan","year":"2014","journal-title":"Endocr Pract"},{"key":"10.1016\/j.cgh.2024.09.038_bib42","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jhep.2010.04.030","article-title":"Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes","volume":"53","author":"Targher","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2024.09.038_bib43","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1464-5491.2009.02839.x","article-title":"Abnormal liver function tests in patients with type 1 diabetes mellitus: prevalence, clinical correlations and underlying pathologies","volume":"26","author":"Leeds","year":"2009","journal-title":"Diabet Med"},{"key":"10.1016\/j.cgh.2024.09.038_bib44","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.dld.2011.12.005","article-title":"Screening for liver fibrosis by using FibroScan(\u00ae) and FibroTest in patients with diabetes","volume":"44","author":"de L\u00e9dinghen","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2024.09.038_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jus.2008.12.002","article-title":"Nonalcoholic fatty liver disease (NAFLD) in nonobese patients with diabetes: prevalence and relationships with hemodynamic alterations detected with Doppler sonography","volume":"12","author":"Gaiani","year":"2009","journal-title":"J Ultrasound"},{"key":"10.1016\/j.cgh.2024.09.038_bib46","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/jgh.13814","article-title":"Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes","volume":"33","author":"Svikl\u0101ne","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.09.038_bib47","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.diabet.2018.03.002","article-title":"Prevalence and clinical characteristics of non-alcoholic fatty liver disease in newly diagnosed patients with ketosis-onset diabetes","volume":"44","author":"Li","year":"2018","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.cgh.2024.09.038_bib48","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","article-title":"The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with type 2 diabetes","volume":"22","author":"Younossi","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.09.038_bib49","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1136\/gutjnl-2023-330110","article-title":"Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis","volume":"72","author":"En Li Cho","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.09.038_bib50","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1210\/jc.2014-3050","article-title":"Liver fat content and hepatic insulin sensitivity in overweight patients with type 1 diabetes","volume":"100","author":"Llaurad\u00f3","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cgh.2024.09.038_bib51","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12933-024-02145-x","article-title":"Double diabetes-when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition","volume":"23","author":"Bielka","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cgh.2024.09.038_bib52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12902-021-00851-1","article-title":"The association between overweight\/obesity and double diabetes in adults with type 1 diabetes; a cross-sectional study","volume":"21","author":"Cantley","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.cgh.2024.09.038_bib53","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","article-title":"Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study","volume":"155","author":"Vilar-Gomez","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.09.038_bib54","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD","volume":"67","author":"Hagstr\u00f6m","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2024.09.038_bib55","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/hepr.14025","article-title":"Glycemic control target for liver and cardiovascular events risk in metabolic dysfunction-associated steatotic liver disease","volume":"54","author":"Tamaki","year":"2024","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cgh.2024.09.038_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111820","article-title":"Glycated haemoglobin is a major predictor of disease severity in patients with NAFLD","volume":"217","author":"Colosimo","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.cgh.2024.09.038_bib57","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/hep.31806","article-title":"Glycemic control predicts severity of hepatocyte ballooning and hepatic fibrosis in nonalcoholic fatty liver disease","volume":"74","author":"Alexopoulos","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2024.09.038_bib58","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.metabol.2017.11.003","article-title":"Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis","volume":"79","author":"Mantovani","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.cgh.2024.09.038_bib59","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00125-010-1720-1","article-title":"Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients","volume":"53","author":"Targher","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.cgh.2024.09.038_bib60","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2337\/dc13-2704","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes","volume":"37","author":"Targher","year":"2014","journal-title":"Diabetes Care"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524010668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524010668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:13:03Z","timestamp":1762549983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356524010668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1542356524010668"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2024.09.038","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global Epidemiology and Characteristics of Metabolic Dysfunction-associated Steatotic Liver Disease in Type 1 Diabetes Mellitus: An Updated Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2024.09.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the AGA Institute","name":"copyright","label":"Copyright"}]}}